NCT07551271

Brief Summary

A study on the therapeutic effect of platelet-rich plasma in the treatment of androgenetic alopecia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 19, 2026

Last Update Submit

April 19, 2026

Conditions

Androgenetic Alopecia (AGA)

Keywords

Androgenetic alopeciaPlatelet-rich plasmaMinoxidilDermoscpe

Outcome Measures

Primary Outcomes (2)

  • Dermoscope

    The amount of hair on the parietal and posterior occipital regions

    before the first treatment and 1,2,3 and 6 months after the treatment

  • MRI

    Hair follicle density on the parietal and posterior occipital regions

    before the first treatment and 6 months after the treatment

Study Arms (1)

group A

EXPERIMENTAL

platelet-rich plasma combined with minoxidil

Drug: PRP

Interventions

PRPDRUG

group A was treated with platelet-rich plasma combined with external Minoxidil , group B was treated with external Minoxidil

Also known as: plitelet-rich plasma
group A

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • moderate to severe androgenic Alopecia

You may not qualify if:

  • abnormal coagulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215300, China

Location

MeSH Terms

Conditions

Alopecia

Condition Hierarchy (Ancestors)

HypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2026

First Posted

April 24, 2026

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

March 1, 2026

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations

CN(1)